Candriam SCA’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-45,398
| Closed | -$659K | – | 909 |
|
|
2022
Q4 | $659K | Buy |
45,398
+1,241
| +3% | +$18K | ﹤0.01% | 772 |
|
|
2022
Q3 | $843K | Buy |
+44,157
| New | +$843K | 0.01% | 749 |
|
|
2019
Q2 | – | Sell |
-131,732
| Closed | -$4.37M | – | 826 |
|
|
2019
Q1 | $4.37M | Buy |
+131,732
| New | +$4.37M | 0.06% | 354 |
|
|
2017
Q2 | – | Sell |
-74,000
| Closed | -$1.42M | – | 716 |
|
|
2017
Q1 | $1.42M | Hold |
74,000
| – | – | 0.03% | 505 |
|
|
2016
Q4 | $1.23M | Buy |
+74,000
| New | +$1.23M | 0.03% | 478 |
|